首页 | 本学科首页   官方微博 | 高级检索  
     


Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Authors:Ali Afshar-Oromieh  Christian M. Zechmann  Anna Malcher  Matthias Eder  Michael Eisenhut  Heinz G. Linhart  Tim Holland-Letz  Boris A. Hadaschik  Frederik L. Giesel  Jürgen Debus  Uwe Haberkorn
Affiliation:1. Department of Nuclear Medicine, University Hospital of Heidelberg, INF 400, 69120, Heidelberg, Germany
2. Department of Radiopharmaceutical Chemistry, German Cancer Research Centre, Im Neuenheimer Feld 280, Heidelberg, Germany
3. National Centre for Tumor Diseases (NCT)/DKFZ, INF 581, 69120, Heidelberg, Germany
4. Department of Biostatistics, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg, Germany
5. Department of Urology, University Hospital of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, Germany
6. Department of Radiation Oncology, University Hospital of Heidelberg, INF 400, 69120, Heidelberg, Germany
7. Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Centre, Heidelberg, Germany
Abstract:

Purpose

Positron emission tomography (PET) with choline tracers has found widespread use for the diagnosis of prostate cancer (PC). However, choline metabolism is not increased in a considerable number of cases, whereas prostate-specific membrane antigen (PSMA) is overexpressed in most PCs. Therefore, a 68Ga-labelled PSMA ligand could be superior to choline tracers by obtaining a high contrast. The aim of this study was to compare such a novel tracer with standard choline-based PET/CT.

Methods

Thirty-seven patients with biochemical relapse of PC [mean prostate-specific antigen (PSA) 11.1?±?24.1 ng/ml, range 0.01–116] were retrospectively analysed after 18F-fluoromethylcholine and 68Ga-PSMA PET/CT within a time window of 30 days. Radiotracer uptake that was visually considered as PC was semi-quantitatively analysed by measuring the maximum standardized uptake values (SUVmax) of the scans acquired 1 h after injection of 68Ga-PSMA complex solution (median 132 MBq, range 59–263 MBq) and 18F-fluoromethylcholine (median 237 MBq, range 114–374 MBq), respectively. In addition, tumour to background ratios were calculated.

Results

A total of 78 lesions characteristic for PC were detected in 32 patients using 68Ga-PSMA PET/CT and 56 lesions were detected in 26 patients using choline PET/CT. The higher detection rate in 68Ga-PSMA PET/CT was statistically significant (p?=?0.04). In five patients no lesion was found with both methods. All lesions detected by 18F-fluoromethylcholine PET/CT were also seen by 68Ga-PSMA PET/CT. In 68Ga-PSMA PET/CT SUVmax was clearly (>10 %) higher in 62 of 78 lesions (79.1 %) and the tumour to background ratio was clearly (>10 %) higher in 74 of 78 lesions (94.9 %) when compared to 18F-fluoromethylcholine PET/CT.

Conclusion

68Ga-PSMA PET/CT can detect lesions characteristic for PC with improved contrast when compared to standard 18F-fluoromethylcholine PET/CT, especially at low PSA levels.
Keywords:
本文献已被 SpringerLink 等数据库收录！
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号